| http://www.w3.org/ns/prov#value | - This could limit the generalizability of our findings, including the interpretation of the molecular correlates, especially the mutational analyses.Another finding in our study was the lack of a clear correlation between pERK or pAKT immunostaining and mPFS. Interestingly, patients with pERK score lower than 1 included 80% of patients whose disease progressed and none of the patients who experienc
|
